Skip to main content

Idarucizumab Side Effects

Medically reviewed by Drugs.com. Last updated on Dec 23, 2023.

Applies to idarucizumab: intravenous solution.

Serious side effects of Idarucizumab

Along with its needed effects, idarucizumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking idarucizumab:

Incidence not known

For Healthcare Professionals

Applies to idarucizumab: intravenous solution.

General

The most common adverse reactions were hypokalemia, delirium, constipation, pyrexia, pneumonia, and headache.[Ref]

Cardiovascular

Common (1% to 10%): Thrombotic events[Ref]

Metabolic

Common (1% to 10%): Hypokalemia[Ref]

Psychiatric

Common (1% to 10%): Delirium[Ref]

Gastrointestinal

Common (1% to 10%): Constipation, nausea[Ref]

Other

Common (1% to 10%): Pyrexia[Ref]

Respiratory

Common (1% to 10%): Pneumonia

Frequency not reported: Bronchospasm, hyperventilation[Ref]

Nervous system

Common (1% to 10%): Headache[Ref]

Dermatologic

Frequency not reported: Rash, pruritus[Ref]

Immunologic

Frequency not reported: Hypersensitivity reactions[Ref]

References

1. Cerner Multum, Inc. UK Summary of Product Characteristics.

2. Product Information. Praxbind (idarucizumab). Boehringer Ingelheim. 2016.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.